CoChat
Sign Up
Cited by 1Enzyme Structure and FunctionProtein Structure and DynamicsComputational Drug Discovery Methods

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Structure and catalytic mechanism of methylisocitrate lyase, a potential drug target against Coxiella burnetii

Open access
Stuart, William S., Jenkins, Christopher H., Ireland, Philip M., Isupov, Michail N., Norville, Isobel H., Harmer, Nicholas J.·2025·Journal of Biological Chemistry
DOI 10.1016/j.jbc.2025.108517PMC PMC12145553

Published version of a preprint

Open this paper in CoChat — free account

Abstract

Abstract We present a comprehensive investigation into the catalytic mechanism of methylisocitrate lyase, a potential drug target candidate against the zoonotic pathogen Coxiella burnetii , the causative agent of Q fever and a federal select agent. Current treatment regimens are prolonged, often with incomplete clearance of the pathogen. We utilised a structure-based bioinformatics pipeline to identify methylisocitrate lyase as a candidate therapeutic target against C. burnetii from a list of essential genes. Wild-type C. burnetii methylisocitrate lyase has a k cat of 32,000 s -1 (compared to 105 s -1 for Salmonella enterica ) and isocitrate inhibits with a K I of 6 mM. We have determined the previously uncharacterised substrate-bound structure of this enzyme family, alongside product and inhibitor-bound structures. These structures of wild-type enzyme reveal that in the active state the catalytic C118 is positioned 2.98 Å from O5 of methylisocitrate and Arg152 moves towards the substrate relative to the inhibitor bound structure. Analysis of structure-based mutants reveals that Arg152 and Glu110 are both essential for catalysis. We suggest that Arg152 acts as the catalytic base that initiates the methylisocitrate lyase reaction. These results deepen our understanding of the catalytic mechanism of methylisocitrate lyase and could aid the development of new therapeutics against C. burnetii .

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jbc.2025.108517

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 55

  1. Celina, 2022, In ticks, livestock, pets and wildlife: a mini-review, Front. Vet. Sci., 9, 10.3389/fvets.2022.1068129 · DOI
  2. Cross, 2019, Zoonoses under our noses, Microbes Infect., 21, 10, 10.1016/j.micinf.2018.06.001 · DOI
  3. Tan, 2024, A systematic review of global Q fever outbreaks, One Health, 18, 10.1016/j.onehlt.2023.100667 · DOI
  4. Morroy, 2012, Of goats and humans; the societal costs of the Dutch Q fever saga, Int. J. Infect. Dis., 16, 10.1016/j.ijid.2012.05.914 · DOI
  5. Raijmakers, 2020, Multi-omics examination of Q fever fatigue syndrome identifies similarities with chronic fatigue syndrome, J. Transl. Med., 18, 448, 10.1186/s12967-020-02585-5 · DOI
  6. Reukers, 2022, Impact of Q-fever on physical and psychosocial functioning until 8 years after infection: An integrative data analysis, PLoS One, 17, 10.1371/journal.pone.0263239 · DOI
  7. Clemente, 2023, Establishing the intracellular niche of obligate intracellular vacuolar pathogens, Front. Cell Infect. Microbiol., 13, 10.3389/fcimb.2023.1206037 · DOI
  8. Bauer, 2023, Interdisciplinary studies on Coxiella burnetii: from molecular to cellular, to host, to one health research, Int. J. Med. Microbiol., 313, 10.1016/j.ijmm.2023.151590 · DOI
  9. Seshadri, 2003, Complete genome sequence of the Q-fever pathogen, Proc. Natl. Acad. Sci. U.S.A, 100, 5455, 10.1073/pnas.0931379100 · DOI
  10. Best, 2019, Nutrition and bipartite metabolism of intracellular pathogens, Trends Microbiol., 27, 550, 10.1016/j.tim.2018.12.012 · DOI
  11. Sandoz, 2014, Developmental transitions of Coxiella burnetii grown in axenic media, J. Microbiol. Methods, 96, 104, 10.1016/j.mimet.2013.11.010 · DOI
  12. Anderson, 2013, Diagnosis and management of Q fever - United States, 2013 recommendations from CDC and the Q fever working group, MMWR Recomm Rep., 62, 1
  13. Kersh, 2013, Antimicrobial therapies for Q fever, Expert Rev. Anti-Infective Ther., 11, 1207, 10.1586/14787210.2013.840534 · DOI
  14. Hemsley, 2019, Extensive genome analysis of Coxiella burnetii reveals limited evolution within genomic groups, BMC Genomics, 20, 441, 10.1186/s12864-019-5833-8 · DOI
  15. Metters, 2023, Identification of essential genes in Coxiella burnetii, Microb. Genom, 9
  16. Brock, 2001, 2-Methylisocitrate lyases from the bacterium and the filamentous fungus: characterization and comparison of both enzymes, Eur. J. Biochem., 268, 3577, 10.1046/j.1432-1327.2001.02262.x · DOI
  17. Horswill, 1999, Salmonella typhimurium LT2 catabolizes propionate via the 2-methylcitric acid cycle, J. Bacteriol., 181, 5615, 10.1128/JB.181.18.5615-5623.1999 · DOI
  18. Textor, 1997, Propionate oxidation in Escherichia coli: evidence for operation of a methylcitrate cycle in bacteria, Arch. Microbiol., 168, 428, 10.1007/s002030050518 · DOI
  19. Dolan, 2018, Loving the poison: the methylcitrate cycle and bacterial pathogenesis, Microbiology-Sgm, 164, 251, 10.1099/mic.0.000604 · DOI
  20. Pham, 2017, Mechanism-based inactivator of isocitrate lyases 1 and 2 from, Proc. Natl. Acad. Sci. U.S.A, 114, 7617, 10.1073/pnas.1706134114 · DOI
  21. Honer Zu Bentrup, 1999, Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis, J. Bacteriol., 181, 7161, 10.1128/JB.181.23.7161-7167.1999 · DOI
  22. Eoh, 2014, Methylcitrate cycle defines the bactericidal essentiality of isocitrate lyase for survival of Mycobacterium tuberculosis on fatty acids, Proc. Natl. Acad. Sci. U. S. A, 111v, 4976, 10.1073/pnas.1400390111 · DOI
  23. Grimek, 2003, Residues C123 and D58 of the 2-methylisocitrate lyase (PrpB) enzyme of are essential for catalysis, J. Bacteriol., 185, 4837, 10.1128/JB.185.16.4837-4843.2003 · DOI
  24. Simanshu, 2003, Crystal structure of Salmonella typhimurium 2-methylisocitrate lyase (PrpB) and its complex with pyruvate and Mg(2+), Biochem. Biophys. Res. Commun., 311, 193, 10.1016/j.bbrc.2003.09.193 · DOI
  25. Grimm, 2003, Crystal structure of 2-methylisocitrate lyase (PrpB) from Escherichia coli and modelling of its ligand bound active centre, J. Mol. Biol., 328, 609, 10.1016/S0022-2836(03)00358-9 · DOI
  26. Moynihan, 2014, Cysteine is the general base that Serves in catalysis by isocitrate lyase and in mechanism-based inhibition by 3-Nitropropionate, Biochemistry, 53, 178, 10.1021/bi401432t · DOI
  27. Liu, 2005, Crystal structures of 2-methylisocitrate lyase in complex with product and with isocitrate inhibitor provide insight into lyase substrate specificity, catalysis and evolution, Biochemistry, 44, 2949, 10.1021/bi0479712 · DOI
  28. Park, 2016, Crystal structure and functional analysis of isocitrate lyases from and, J. Struct. Biol., 194, 395, 10.1016/j.jsb.2016.03.019 · DOI
  29. Sharma, 2000, Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis, Nat. Struct. Biol., 7, 663, 10.1038/77964 · DOI
  30. Pundir, 2017, UniProt protein knowledgebase, Methods Mol. Biol., 1558, 41, 10.1007/978-1-4939-6783-4_2 · DOI
  31. Kozlowski, 2016, IPC - isoelectric point calculator, Biol. Direct, 11, 55, 10.1186/s13062-016-0159-9 · DOI
  32. Krogh, 2001, Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes, J. Mol. Biol., 305, 567, 10.1006/jmbi.2000.4315 · DOI · Paper page
  33. Altschul, 1990, Basic local alignment search tool, J. Mol. Biol., 215, 403, 10.1016/S0022-2836(05)80360-2 · DOI · Paper page
  34. Berman, 2000, The protein Data Bank, Nucleic Acids Res., 28, 235, 10.1093/nar/28.1.235 · DOI · Paper page
  35. Miller, 2024, ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics, Nat. Rev. Microbiol., 22, 598, 10.1038/s41579-024-01054-w · DOI
  36. Krivak, 2018, P2Rank: machine learning based tool for rapid and accurate prediction of ligand binding sites from protein structure, J. Cheminform, 10, 39, 10.1186/s13321-018-0285-8 · DOI
  37. Tabuchi, 1976, Purification and Properties of methylisocitrate lyase, a key enzyme in Propionate Metabolism, from Candida lipolytica, Bio. Chem., 74, 169
  38. Müller, 2011, Gene acquisition, duplication and metabolic specification: the evolution of fungal methylisocitrate lyases, Environ. Microbiol., 13, 1534, 10.1111/j.1462-2920.2011.02458.x · DOI
  39. Goodman, 2009, Identifying genetic determinants needed to establish a human gut symbiont in its habitat, Cell Host Microbe, 6, 279, 10.1016/j.chom.2009.08.003 · DOI
  40. van Opijnen, 2009, Tn-seq: high-throughput parallel sequencing for fitness and genetic interaction studies in microorganisms, Nat. Methods, 6, 767, 10.1038/nmeth.1377 · DOI
  41. Kyono, 2024, Technical considerations for cost-effective transposon directed insertion-site sequencing (TraDIS), Sci. Rep., 14, 6756, 10.1038/s41598-024-57537-6 · DOI
  42. Warner, 2023, Microbial Primer: transposon directed insertion site sequencing (TraDIS): a high throughput method for linking genotype to phenotype, Microbiology (Reading), 169, 10.1099/mic.0.001385 · DOI
  43. Olsson, 2011, PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions, J. Chem. Theor. Comput, 7, 525, 10.1021/ct100578z · DOI
  44. Dolan, 2022, Systems-wide dissection of organic acid assimilation in Pseudomonas aeruginosa reveals a novel path to underground metabolism, mbio, 13, 10.1128/mbio.02541-22 · DOI · Paper page
  45. Cross, 2022, Spinning sugars in antigen biosynthesis: characterization of the Coxiella burnetii and Streptomyces griseus TDP-sugar epimerases, J. Biol. Chem., 298, 10.1016/j.jbc.2022.101903 · DOI
  46. Savitsky, 2010, High-throughput production of human proteins for crystallization: the SGC experience, J. Struct. Biol., 172, 3, 10.1016/j.jsb.2010.06.008 · DOI
  47. Winter, 2010, xia2: an expert system for macromolecular crystallography data reduction, J. Appl. Crystallogr., 43, 186, 10.1107/S0021889809045701 · DOI
  48. McCoy, 2007, Phaser crystallographic software, J. Appl. Crystallogr., 40, 658, 10.1107/S0021889807021206 · DOI · Paper page
  49. Murshudov, 2011, REFMAC5 for the refinement of macromolecular crystal structures, Acta Crystallogr. D Biol. Crystallogr., 67, 355, 10.1107/S0907444911001314 · DOI
  50. Krissinel, 2022, CCP4 Cloud for structure determination and project management in macromolecular crystallography, Acta Crystallogr. D Struct. Biol., 78, 1079, 10.1107/S2059798322007987 · DOI
  51. Emsley, 2004, Coot: model-building tools for molecular graphics, Acta Crystallogr. D Biol. Crystallogr., 60, 2126, 10.1107/S0907444904019158 · DOI · Paper page
  52. Croll, 2018, ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps, Acta Crystallogr. D Struct. Biol., 74, 519, 10.1107/S2059798318002425 · DOI
  53. Meng, 2023, UCSF ChimeraX: tools for structure building and analysis, Protein Sci., 32, 10.1002/pro.4792 · DOI
  54. Robert, 2014, Deciphering key features in protein structures with the new ENDscript server, Nucleic Acids Res., 42, W320, 10.1093/nar/gku316 · DOI · Paper page
  55. Laskowski, 2011, LigPlot+: multiple ligand-protein interaction diagrams for drug discovery, J. Chem. Inf. Model., 51, 2778, 10.1021/ci200227u · DOI

Metadata

Authors
Stuart, W. S., Jenkins, C. H., Ireland, P. M., Isupov, M. N., Norville, I. H., & Harmer, N. J.
Affiliations
  • University of Exeter (GB)
  • Defence Science and Technology Laboratory (GB)
Corresponding author
Harmer, Nicholas J.
ORCID
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2025-06
Volume
301
Issue
6
Pages
108517
ISSN
0021-9258 (ISSN-L)
DOI
10.1016/j.jbc.2025.108517
PMC
PMC12145553
OpenAlex
W4409499652
Cited by
1
References
4
Citations by year
2026: 1
FWCI
0.21
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Biotechnology and Biological Sciences Research Council (BB/M009122/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Keywords
Coxiella burnetii, Q fever, catalytic mechanism, therapeutic target, essential genes, enzyme kinetics
MeSH terms
Bacterial Proteins, Catalysis, Enzyme Inhibitors, Coxiella burnetii, Crystallography, X-Ray, Catalytic Domain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structure and catalytic mechanism of methylisocitrate lyase, a potential drug target against Coxiella burnetii. https://app.cochat.ai/papers/10.1016/j.jbc.2025.108517
The paper
Stuart, W. S., Jenkins, C. H., Ireland, P. M., Isupov, M. N., Norville, I. H., & Harmer, N. J. (2025). Structure and catalytic mechanism of methylisocitrate lyase, a potential drug target against Coxiella burnetii. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.108517